openPR Logo
Press release

Market Spotlight: Glaucoma

11-08-2017 09:01 AM CET | Health & Medicine

Press release from: ReportsWorldwide

Boston, MA

ReportsWorldwide has announced the addition of a new report title Market Spotlight: Glaucoma to its growing collection of premium market research reports.

Glaucoma is not just one eye disease, but a group of eye conditions resulting in optic nerve damage, which may cause loss of vision and blindness. In glaucoma, damage to the optic nerve is usually caused by elevated intraocular pressure (IOP). IOP rises when passages that allow fluid to drain become blocked. However, one person may develop nerve damage at a relatively low pressure, while another person may have high pressure for years and yet never develop damage. Although IOP is clearly a risk factor, other risk factors are present.

In the early stages of the disease, there may be no symptoms. It is estimated that 50% of the people who have glaucoma are not being treated as they are not aware that they have the disease. Glaucoma is one of the leading causes of blindness in the US. Loss of vision may be so gradual it may be overlooked until the disease is at an advanced stage.

The most common type of glaucoma, primary open-angle glaucoma, has no noticeable signs or symptoms except gradual vision loss. Early diagnosis and treatment can minimize or prevent optic nerve damage and limit glaucoma-related vision loss. Regular eye exams and measures of ocular pressure are the best means to prevent this disease.

For a Detailed description and table of contents of this report please click here: https://www.reportsworldwide.com/report/market-spotlight-glaucoma

This Market Spotlight report covers the Glaucoma market, comprising key pipeline and marketed drugs, clinical trials, upcoming and regulatory events, patent information, a 10-year disease prevalence forecast, and licensing and acquisition deals, as well as presenting drug-specific revenue forecasts.

Data within this Market Spotlight report are sourced from across the Informa Pharma Intelligence suite of products, including Biomedtracker, Pharmaprojects, Trialtrove, and Medtrack, as well as Datamonitor Healthcare. The report also features content from Scrip, Pink Sheet, and Medtech Insight.

To Get Sample Copy of Report please visit @ https://www.reportsworldwide.com/enquiry?report_id=41338

About ReportsWorldwide.com

ReportsWorldwide.com is a leading provider of global market intelligence reports and services. With research reports from top publishers, consulting and advisory firms, ReportsWorldwide.com offers instant online access to a growing database of expert insights on global industries, companies, products, geographies and trends.

Press Contact:
Abigail Crasto
Senior Vice President
101, Arch Street
Boston, MA 02110
US
Phone +1 (617) 398-1947
abigail@reportsworldwide.com

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Market Spotlight: Glaucoma here

News-ID: 806669 • Views: 9688

More Releases from ReportsWorldwide

World Deep Brain Stimulation Market Top Segments, Key Players Revenue, Growth Ra …
The World Deep Brain Stimulation Market is estimated to represent a global market of USD 751.8 million by 2017 with growth rate of 18.2%. Deep brain stimulation (DBS) procedure is primarily used for the treatment of neuropsychiatric disorders such as mood disorder, dementia, anxiety and others. The procedure involve the use of neurotransmitter (brain pacemaker) that enables to transmit electric impulses to the specific target of brain cells. Increasing incidence
New report explores the Gene Editing Market : Ushering The Next Breakthrough in …
Boston, MA ReportsWorldwide has announced the addition of a new report title Gene Editing The Next Breakthrough in Regenerative Medicine to its growing collection of premium market research reports. Genome editing is a type of genetic engineering in which DNA is replaced, inserted or deleted in a living organism's ggenome using engineered molecular scissors. Believed to be one of the great biotechnology breakthroughs, gene editing is a powerful tool in pharmaceutical research that
Global In-Building Wireless BTSController-based Small Cells Market Analysis and …
Boston, MA ReportsWorldwide has announced the addition of a new report title Global In-Building Wireless BTSController-based Small Cells Market Analysis and Forecast, 2017-2021 to its growing collection of premium market research reports. This report covers the leading in-building wireless enterprise BTS/controller-based small cells network equipment manufacturers: • CommScope/Airvana • Comba Telecom • Ericsson • Huawei Technologies • Nokia • SpiderCloud • ZTE Corporation This report covers the global market share for 2016 shipments as well as a forecast for 2017-2021. To view a detailed description and Table of
UDAY’s Impact and Compatibility State wise indexing of Integrated Power Supply …
Boston, MA ReportsWorldwide has announced the addition of a new report title UDAY’s Impact and Compatibility State wise indexing of Integrated Power Supply Chain in India – 2017 to its growing collection of premium market research reports. UDAY scheme was touted as the next paladin to bail out the struggling Discoms, in order to turn them green in a time horizon of 3-4 years from 2015/16. Though was optional for the

All 5 Releases


More Releases for Glaucoma

Glaucoma – Epidemiology Insights (2016-2028)
Glaucoma can be described as a group of diseases characterized by cupping of the optic nerve head and visual-field damage. These diseases differ from each other in terms of their causes, risk factors, demographics, symptoms, duration, treatment, and prognosis. Download the sample report @ https://www.pharmaproff.com/request-sample/1159 The common identifiable features for all forms of glaucoma are loss of retinal ganglion cells, thinning of the retinal nerve fiber layer, and cupping of the
Glaucoma Treatment Pharmaceutical and Healthcare Analysis Information
Report Description This report analyzes the Asia-pacific glaucoma treatment market by disease indication (closed angle glaucoma (CAG), open angle glaucoma (OAG), secondary glaucoma, congenital glaucoma and other), drug class (prostaglandin analogs (PGAS), alpha agonist, beta blockers, cholinergic drugs, carbonic anhydrase inhibitors, and others), surgery (laser iridotomy, laser trabeculoplasty, aqueous shunt surgery and peripheral iridectomy) and by end users (hospitals and home users); it also studies the top manufacturers in the
Market Overview of Glaucoma pipeline Landscape
Summary Glaucoma is a disease of the eye in which fluid pressure within the eye rises. The exact cause of optic nerve damage from glaucoma is not fully understood, but involves mechanical compression and/or decreased blood flow of the optic nerve. The most important risk factors include age, elevated eye pressure, African ancestry, thin cornea, family history of glaucoma. Signs and symptoms include eye pain, nausea and vomiting (accompanying the severe
Glaucoma Surgery Devices Market 2016: Glaucoma Systems, Glaucoma Laser Devices
Latest industry research report on Glaucoma surgery devices are used in the glaucoma treating procedure. These procedures include both surgical and laser therapies performed on a patient. The cases of blindness due to glaucoma is on rise across the several countries. Furthermore, the demand for both technologically as well as advanced surgical equipment has resulted in the popularity of glaucoma surgery devices industry, worldwide. Sudden increase in the aging population and
Can yoga worsen glaucoma?
Patients with glaucoma are encouraged to exercise and lead healthy and active lifestyle, but should avoid activities that increase the eye pressure and damage the optic nerve. Push-ups and heavy weight lifting are not advisable, so is certain yoga postures in which the head is facing downward. Previous studies have investigated only headstand position which showed a remarkable two-fold increase in eye pressure. However, a new research carried out at
Cataracts and Glaucoma - The Differences Explained
Ethos Bright Eyes NAC Cataracts Eye drops dissolve cataracts naturally without invasive surgery Cataracts and Glaucoma - The Differences Explained Many will have this kind of question and to know more about this it is better to compare both cataracts and glaucoma so that you will be able to understand each condition much better. Eye cataracts and glaucoma are two totally different eye conditions. Cataracts are a cross-linking of proteins in